Fintel reports that on December 4, 2025, Scotiabank maintained coverage of Bristol-Myers Squibb (NYSE:BMY) with a Sector ...
Bristol-Myers Squibb shares gained after the company announced that it will enroll additional patients in the ADEPT-2 study.
The Prudent Speculator is an investment newsletter that has been published monthly since 1977. Buckingham and his team run four value-stock portfolios. The flagship Prudent Speculator Portfolio has ...
Pfizer(NYSE: PFE) and Bristol Myers Squibb(NYSE: BMY) are two of the largest and most respected pharmaceutical companies in ...
Bayer reported positive Phase 3 results for its FXIa inhibitor asundexian, hitting key efficacy and safety targets ...
The Schwab U.S. Dividend Equity ETF currently trades at about $27 per share. So, your $500 will buy you about 18 shares. The ...
Patience will be rewarded for those who stick with these two healthcare stocks.
One particularly appealing dividend stock right now is Bristol Myers Squibb ( BMY 0.10%). It yields 5.4%, which is an ...
Bristol Myers Squibb BMY and Gilead Sciences, Inc. GILD are leading biotechnology companies with broad, diverse portfolios ...
Bristol-Myers Squibb Company, Newtek Business Services Corp, Sonoco Products Company. Read 's Market Analysis on Investing.com ...
The Coca-Cola Company (NYSE:KO) is one of the stocks Jim Cramer expressed his thoughts on. Noting that they would like to ...
Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback